Disclosed are compounds of Formula I, pharmaceutical compositions comprising Formula I and methods of treating bacterial infections. The disclosed compounds are inhibitors of PPAT (phosphopantetheine adenyl transferase), and are useful in the treatment and prevention of diseases caused by bacteria, particularly bacteria dependent on PPAT, for example, species such
Escherichia coli, Helicobacter pylori, Staphyloccocus aureus
, and the like.
US8124616B2
申请人:——
公开号:US8124616B2
公开(公告)日:2012-02-28
[EN] BICYCLIC PPAT INHIBITORS AS ANTIBACTERIAL AGENTS<br/>[FR] INHIBITEURS DE PPAT BICYCLIQUES UTILISÉS EN TANT QU'AGENTS ANTIBACTÉRIENS